Fierce 15 News Today

SAN JOSE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated...

(GH01/ iStock) Quench Bio’s short journey has come to an end after the biotech startup found that its target was simply undruggable. The Cambridge, Massachusetts-based biotech had focused on blocking the gasdermin D protein with oral inhibitors to treat inflammatory diseases and had attempted to seek out a potent, selective chemical series to progress by the first quarter of 2021. It has not, however, managed to hit that goal, and, with credit to the company, it is not trying to spin...